Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial - Concepedia

Concepedia

Publication | Open Access

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

DOI Full Paper Access

85

Citations

24

References

2021

Year

Timothy Hinks, Lucy Cureton, Ruth Knight, Ariel Wang, Jennifer Cane, Vicki S Barber, Joanna Black, Susan Dutton, J. Mark Melhorn, Maisha Jabeen,

The Lancet Respiratory Medicine

Mild-to-moderate Covid-19AntibioticsStandard CareRandomised TrialCovid-19 PandemicInfection ControlCovid-19 EpidemiologyClinical Infectious DiseaseMedicineClinical MicrobiologyCovid-19

References

	Year	Citations

Page 1

Page 1